A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients
University of Arkansas
University of Arkansas
Numab Therapeutics AG
Intensity Therapeutics, Inc.
Sarcoma Oncology Research Center, LLC
ImmunityBio, Inc.
Federation Francophone de Cancerologie Digestive
Advaxis, Inc.
Genmab
Revolution Medicines, Inc.
The University of Texas Health Science Center at San Antonio
M.D. Anderson Cancer Center
BPGbio
National Institutes of Health Clinical Center (CC)